Press Release

Cooley Advises Apollo Endosurgery in Agreement to Acquire Obesity Intervention Division of Allergan

October 29, 2013

Palo Alto, Calif. – October 29, 2013 – Cooley LLP announced today that it advised Apollo Endosurgery, Inc., a leading developer of medical devices and endoscopic surgical procedures, in its decision to enter a definitive agreement to acquire the obesity intervention division of Allergan, Inc. for up to $110 million. The obesity intervention division of Allergan is responsible for manufacturing the LAP-BAND adjustable gastric band system and the ORBERA intra-gastric balloon system.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors and established companies. Clients partner with Cooley on transformative deals, complex IP matters and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 700 lawyers across eleven offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.